|
Soler-Espejo E, Zazo-Luengo BA, Rivera-Caravaca JM, Lopez-Gavez R, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation. J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29. PubMed PMID: 39615399.
AÑO: 2025; IF: 4.3
|
39615399
|
Rivera-Caravaca JM, Soler-Espejo E, Ramos-Bratos MP, Lopez-Galvez R, Gonzalez-Lozano E, Lip GYH, Marin F, Roldan V. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation. Cardiovasc Diabetol. 2025 Jul 10;24(1):281. doi: 10.1186/s12933-025-02809-2. PubMed PMID: 40640827; PubMed Central PMCID: PMC12247220.
AÑO: 2025; IF: 8.5
|
|
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Ramos-Bratos MP, Lopez-Galvez R, Marin F, Roldan V, Lip GYH. Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study. Cardiovasc Diabetol. 2025 Jul 10;24(1):275. doi: 10.1186/s12933-025-02831-4. PubMed PMID: 40640836; PubMed Central PMCID: PMC12243276.
AÑO: 2025; IF: 8.5
|
|
Mandaglio-Collados D, Ruiz-Alcaraz AJ, Rivera-Caravaca JM, Ramos-Bratos MP, Marin F, Lopez-Galvez R. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes. Environ Toxicol Pharmacol. 2025 Feb 9;114:104652. doi: 10.1016/j.etap.2025.104652. Online ahead of print. PubMed PMID: 39933631.
AÑO: 2025; IF: 4.2
|
|
Serna MJ, Rivera-Caravaca JM, Lopez-Galvez R, Soler-Espejo E, Lip GYH, Marin F, Roldan V. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):835-842. doi: 10.1016/j.rec.2024.02.011. Epub 2024 Mar 7. English, Spanish. PubMed PMID: 38460882.
AÑO: 2024; IF: 5.9
|